News
A Team of Researchers Has Leveraged Two New Molecules, One of Which is Currently in ... - Latest Tweet by IANS Tweets
The latest Tweet by IANS Tweets states, 'A team of researchers has leveraged two new molecules, one of which is currently in clinical oncology trials, to devise a dual-drug therapy for alcohol use disorder , without the side-effects or complications associated with current treatment regimens.'
A team of researchers has leveraged two new molecules, one of which is currently in clinical oncology trials, to devise a dual-drug therapy for alcohol use disorder (AUD), without the side-effects or complications associated with current treatment regimens. pic.twitter.com/Y418rfJ7Ok— IANS Tweets (@ians_india) July 31, 2021
(The above story first appeared on LatestLY on Jul 31, 2021 11:04 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
